THERAPEUTIC AREAS

Browse Biotech by Sector

BiotechSign tracks companies across all major therapeutic areas. Each sector hub shows grades, BiotechSign scores, and upcoming FDA PDUFA catalyst data for companies in that space. Select a sector below to see ranked companies and catalyst timelines.

← Full ScreenerFDA Calendar
Oncology
Cancer drug development — the largest and most traded segment of biotech.
Browse Oncology companies →
Gene Therapy
One-time curative treatments using viral vectors like AAV to deliver functional genes.
Browse Gene Therapy companies →
Gene Editing
CRISPR/Cas9, base editing, and prime editing technologies for permanent DNA modification.
Browse Gene Editing companies →
Rare Disease
Orphan drug development with FDA incentives, Priority Review, and high binary PDUFA impact.
Browse Rare Disease companies →
Neurology & CNS
Alzheimer's, Parkinson's, ALS, depression, and epilepsy drugs with notoriously high failure rates.
Browse Neurology & CNS companies →
Immunology
Autoimmune conditions including rheumatoid arthritis, IBD, psoriasis, and lupus.
Browse Immunology companies →
Infectious Disease
Antivirals, antibiotics, antifungals, vaccines, and pandemic preparedness.
Browse Infectious Disease companies →
Precision Oncology
Biomarker-driven cancer therapies matched to specific molecular tumor alterations.
Browse Precision Oncology companies →
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Always conduct your own due diligence before making investment decisions.